Publications or Presentations Sample Clauses

Publications or Presentations. 16. The contractor will provide the PTS with a copy of any publication or presentation in advance. If the PTS does not raise any objections within five working days after the receipt by the PTS of the advance copy, the publication or presentation shall be considered as approved. While considering the request for publication or presentation, the PTS will verify that the publication or presentation is limited to the reflection of scientific achievements only. A disclaimer, stating that the PTS is not responsible for the views of the author, should be included in the publication or presentation. Implementation
AutoNDA by SimpleDocs
Publications or Presentations. Notwithstanding anything set forth in this Agreement to the contrary, with respect to research and development activities conducted or sponsored by NK, whether through its employees, subcontractors, agents, or any academic, governmental, or other independent contractors, NK agrees that prior to making, allowing or authorizing any presentations or publications relating to the results of such activities (each individually a “Publication”) in the Territory or the NeoPharm Territory, NK shall provide NeoPharm with a copy of any proposed Publication at least thirty (30) days prior to such submission, presentation or publication thereof. NK will not submit, permit or authorize such a Publication without prior written consent of NeoPharm, which consent, however, shall not be unreasonably withheld. If NeoPharm fails to object to a proposed Publication within such thirty (30) day time period, NeoPharm shall be deemed to have consented to the submission, presentation or publication of such Publication.
Publications or Presentations. Both Parties shall have the right to make public announcements regarding Licensed Product in accordance with Article 13 below. Furthermore, Xxxxxxx acknowledges that Genmab, its Affiliates or their employees, and certain Third Parties [***] may wish to present or publish parts of the Licensed Know-How in order to inform the scientific community or public of their work, and in principle agrees that such publication or presentation may be desirable, subject to balancing the benefits of such publication or presentation against any prejudice to the value of the rights and licenses granted to Xxxxxxx hereunder. In such cases, Genmab shall provide a copy to Xxxxxxx’x Alliance Manager of the desired publication or presentation and Xxxxxxx shall consider the same in good faith. Genmab or its staff or [***] shall be permitted to submit such publication or make such presentation if Xxxxxxx gives its prior written consent (not to be unreasonably withheld or delayed). For the purposes of the foregoing, Xxxxxxx shall be deemed to have given its prior written consent to Genmab’s proposed publication or presentation if it does not notify Genmab in writing of its objection thereto within [***] calendar days of Genmab providing Xxxxxxx’x Alliance Manager with a copy of the publication or presentation as set out above. If Xxxxxxx withholds such consent, the Parties shall discuss the situation in good faith with a view to amending such publication or presentation or to delay the publication for sufficient time to file a patent application, if necessary or possible, in order to overcome Xxxxxxx’x objections. It is agreed that Xxxxxxx shall not be entitled to withhold consent to the publication or presentation of information which is already in the public domain, except to the extent that such publication or presentation would be inaccurate or misleading and thereby likely to prejudice the exercise by Xxxxxxx of its rights and licenses hereunder, and that Xxxxxxx shall not be entitled to withhold its consent hereunder in any manner or circumstances that would be incompatible or inconsistent with Genmab’s corresponding obligations to Third Parties under [***]. With respect to any proposed abstracts, manuscripts or summaries of presentations by investigators or other Third Parties, such materials shall be subject to review under this Clause 8.6 to the extent that Genmab has the right and ability (after using reasonable efforts) to do so.
Publications or Presentations. Clementia shall have the right to publish or otherwise present any Data or other results generated under this Agreement in its sole discretion.
Publications or Presentations 

Related to Publications or Presentations

  • Publications and Presentations For purposes of this Agreement, “Scientific Publication” means any scientific publication or medical communication regarding Study results in any form that is intended for disclosure to third parties, including, without limitation, manuscripts, abstracts, posters, slides or other materials used for presentations. 10. Publikace a prezentace. „Vědecká publikace“ znamená pro účely této Smlouvy každou vědeckou publikaci nebo lékařské sdělení týkající se výsledků Studie, v libovolné formě určené ke sdělení třetím stranám, zejména rukopisy, abstrakty, postery, snímky nebo jiné materiály používané pro prezentace.

  • Publications All published material and written reports submitted under the Contract must be originally developed material unless otherwise specifically provided in the Contract. When material not originally developed is included in a report in any form, the source shall be identified.

  • Publicity The Company, and the Buyer shall have the right to review a reasonable period of time before issuance of any press releases, SEC, OTCBB or FINRA filings, or any other public statements with respect to the transactions contemplated hereby; provided, however, that the Company shall be entitled, without the prior approval of the Buyer, to make any press release or SEC, OTCBB (or other applicable trading market) or FINRA filings with respect to such transactions as is required by applicable law and regulations (although the Buyer shall be consulted by the Company in connection with any such press release prior to its release and shall be provided with a copy thereof and be given an opportunity to comment thereon).

  • Other Information and Inspections In each case subject to the last sentence of this Section 6.3, each Restricted Person will furnish to each Lender any information which Administrative Agent or any Lender may from time to time request concerning any covenant, provision or condition of the Loan Documents or any matter in connection with Restricted Persons' businesses and operations. In each case subject to the last sentence of this Section 6.3, each Restricted Person will permit representatives appointed by Administrative Agent (including independent accountants, auditors, agents, attorneys, appraisers and any other Persons) to visit and inspect during normal business hours any of such Restricted Person's property, including its books of account, other books and records, and any facilities or other business assets, and to make extra copies therefrom and photocopies and photographs thereof, and to write down and record any information such representatives obtain, and each Restricted Person shall permit Administrative Agent or its representatives to investigate and verify the accuracy of the information furnished to Administrative Agent or any Lender in connection with the Loan Documents and to discuss all such matters with its officers, employees and, upon prior notice to Borrower, its representatives. Each of the foregoing inspections shall be made subject to compliance with applicable safety standards and the same conditions applicable to any Restricted Person in respect of property of that Restricted Person on the premises of Persons other than a Restricted Person or an Affiliate of a Restricted Person, and all information, books and records furnished or requested to be furnished, or of which copies, photocopies or photographs are made or requested to be made, all information to be investigated or verified and all discussions conducted with any officer, employee or representative of any Restricted Person shall be subject to any applicable attorney-client privilege exceptions which the Restricted Person determines is reasonably necessary and compliance with conditions to disclosures under non-disclosure agreements between any Restricted Person and Persons other than a Restricted Person or an Affiliate of a Restricted Person and the express undertaking of each Person acting at the direction of or on behalf of any Lender Party to be bound by the confidentiality provisions of Section 10.6 of this Agreement.

  • REPRESENTATIONS OF ADVISER The Adviser represents, warrants and agrees as follows:

  • Provision of further information The Borrower will, as soon as practicable after receiving the request, provide the Agent with any additional financial or other information relating:

  • Representations and Agreements (a) The Advisor represents to and agrees with the Company that:

  • Representations of Company (a) Company represents and warrants that the Variable Accounts have been established and are in good standing under the laws of their state of organization; and the Variable Accounts have been registered as unit investment trusts under the 1940 Act and will remain so registered, or are exempt from registration pursuant to Section 3(c)(11) of the 1940 Act;

Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!